Anthelmintic Drugs Market Size, Share, Analysis, Trends, Growth, 2032

Anthelmintic Drugs Market

Anthelmintic Drugs Market by Drug Class (Benzimidazoles, Piperazine, Imidazothiazole, Spiroindoles, Others) by Route of Administration (Oral, Injectable) by Application (Human, Animal) by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032-

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-5853 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.75 Billion USD 3.85 Billion 3.8% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description
      • 1.1.1. Objective
      • 1.1.2. Target Audience
      • 1.1.3. Unique Selling Proposition (USP) & Offerings
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
      • 1.3.3. Level 1: Primary Research
      • 1.3.4. Level 2: Secondary Research
      • 1.3.5. Level 3: Data Validation and Expert Panel Assessment Report Description and Scope
  • Chapter 2. Executive Summary
    • 2.1. Global Anthelmintic Drugs Market, 2016-2026, (USD Million)
    • 2.2. Anthelmintic Drugs Market: Market snapshot
  • Chapter 3. Global Anthelmintic Drugs Market – Industry Analysis
    • 3.1. Introduction
    • 3.2. Industry ecosystem analysis
    • 3.3. Route of Administration landscape
    • 3.4. Market Drivers
      • 3.4.1. North America
      • 3.4.2. Europe
      • 3.4.3. Asia Pacific
      • 3.4.4. Latin America
      • 3.4.5. MEA
    • 3.5. Restraints
    • 3.6. Opportunity
    • 3.7. Innovation & sustainability
    • 3.8. Regulatory landscape
    • 3.9. Porter’s Five Forces Analysis
    • 3.10. PESTLE Analysis
    • 3.11. Anthelmintic Drugs Market: Market Attractiveness Analysis
      • 3.11.1. Market Attractiveness Analysis by Drug Class Segment
      • 3.11.2. Market Attractiveness Analysis by Route of Administration Segment
      • 3.11.3. Market Attractiveness Analysis by Application Segment
      • 3.11.4. Market Attractiveness Analysis by Distribution Channel Segment
  • Chapter 4. Global Anthelmintic Drugs Market - Competitive Landscape
    • 4.1. Company Market Share Analysis, 2019
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions and Mergers
      • 4.2.2. New Product Launch
      • 4.2.3. Agreements, Partnerships, Cullaborations and Joint Ventures
      • 4.2.4. Research & Development and Regional Expansion
  • Chapter 5. Anthelmintic Drugs Market – Drug Class Segment Analysis
    • 5.1. Global Anthelmintic Drugs Market Revenue Share, by Drug Class, 2019 & 2026 (USD Million)
    • 5.2. Global Anthelmintic Drugs Market by Benzimidazules, 2016 – 2026 (USD Million)
    • 5.3. Global Anthelmintic Drugs Market by Piperazine, 2016 – 2026 (USD Million)
    • 5.4. Global Anthelmintic Drugs Market by Imidazothiazule, 2016 – 2026 (USD Million)
    • 5.5. Global Anthelmintic Drugs Market by Spiroindules, 2016 – 2026 (USD Million)
    • 5.6. Global Anthelmintic Drugs Market by Others, 2016 – 2026 (USD Million)
  • Chapter 6. Anthelmintic Drugs Market – Route of Administration Segment Analysis
    • 6.1. Global Anthelmintic Drugs Market Revenue Share, by Route of Administration, 2019 & 2026 (USD Million)
    • 6.2. Global Anthelmintic Drugs Market by Oral, 2016 – 2026 (USD Million)
    • 6.3. Global Anthelmintic Drugs Market by Injectable, 2016 – 2026 (USD Million)
  • Chapter 7. Anthelmintic Drugs Market – Application Segment Analysis
    • 7.1. Global Anthelmintic Drugs Market Revenue Share, by Application, 2019 & 2026 (USD Million)
    • 7.2. Global Anthelmintic Drugs Market by Human, 2016 – 2026 (USD Million)
    • 7.3. Global Anthelmintic Drugs Market by Animal, 2016 – 2026 (USD Million)
  • Chapter 8. Anthelmintic Drugs Market – Distribution Channel Segment Analysis
    • 8.1. Global Anthelmintic Drugs Market Revenue Share, by Distribution Channel, 2019 & 2026 (USD Million)
    • 8.2. Global Anthelmintic Drugs Market by Hospital Pharmacies, 2016 – 2026 (USD Million)
    • 8.3. Global Anthelmintic Drugs Market by Retail Pharmacies, 2016 – 2026 (USD Million)
    • 8.4. Global Anthelmintic Drugs Market by Online Pharmacies, 2016 – 2026 (USD Million)
    • 8.5. Global Anthelmintic Drugs Market by Veterinary Pharmacies, 2016 – 2026 (USD Million)
    • 8.6. Global Anthelmintic Drugs Market by Others, 2016 – 2026 (USD Million)
  • Chapter 9. Anthelmintic Drugs Market - Regional Analysis
    • 9.1. Global Anthelmintic Drugs Market: Regional Overview
      • 9.1.1. Global Anthelmintic Drugs Market Revenue Share, By Region, 2019 & 2026 (USD Million)
    • 9.2. North America
      • 9.2.1. North America Anthelmintic Drugs Market Revenue 2016 – 2026 (USD Million)
      • 9.2.2. North America Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million)
      • 9.2.3. North America Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
      • 9.2.4. North America Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
      • 9.2.5. North America Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
      • 9.2.6. U.S.
        • 9.2.6.1. U.S. Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.2.6.2. U.S. Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.2.6.3. U.S. Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.2.6.4. U.S. Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.2.7. Canada
        • 9.2.7.1. Canada Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.2.7.2. Canada Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.2.7.3. Canada Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.2.7.4. Canada Education & Learning Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.2.8. Mexico
        • 9.2.8.1. Mexico Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.2.8.2. Mexico Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.2.8.3. Mexico Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.2.8.4. Mexico Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe Anthelmintic Drugs Market Revenue 2016 – 2026 (USD Million)
      • 9.3.2. Europe Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million)
      • 9.3.3. Europe Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
      • 9.3.4. Europe Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
      • 9.3.5. Europe Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
      • 9.3.6. UK
        • 9.3.6.1. UK Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.3.6.2. UK Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.3.6.3. UK Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.3.6.4. UK Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.3.7. France
        • 9.3.7.1. France Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.3.7.2. France Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.3.7.3. France Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.3.7.4. France Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.3.8. Germany
        • 9.3.8.1. Germany Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.3.8.2. Germany Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.3.8.3. Germany Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.3.8.4. Germany Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.3.9. Italy
        • 9.3.9.1. Italy Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.3.9.2. Italy Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.3.9.3. Italy Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.3.9.4. Italy Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.3.10. Spain
        • 9.3.10.1. Spain Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.3.10.2. Spain Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.3.10.3. Spain Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.3.10.4. Spain Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.3.11. Russia
        • 9.3.11.1. Russia Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.3.11.2. Russia Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.3.11.3. Russia Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.3.11.4. Russia Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.3.12. Rest of Europe
        • 9.3.12.1. Rest of Europe Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.3.12.2. Rest of Europe Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.3.12.3. Rest of Europe Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.3.12.4. Rest of Europe Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Anthelmintic Drugs Market Revenue 2016 – 2026 (USD Million)
      • 9.4.2. Asia Pacific Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million)
      • 9.4.3. Asia Pacific Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
      • 9.4.4. Asia Pacific Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
      • 9.4.5. Asia Pacific Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
      • 9.4.6. China
        • 9.4.6.1. China Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.4.6.2. China Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.4.6.3. China Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.4.6.4. China Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.4.7. Japan
        • 9.4.7.1. Japan Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.4.7.2. Japan Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.4.7.3. Japan Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.4.7.4. Japan Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.4.8. India
        • 9.4.8.1. India Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.4.8.2. India Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.4.8.3. India Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.4.8.4. India Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.4.9. Australia
        • 9.4.9.1. Australia Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.4.9.2. Australia Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.4.9.3. Australia Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.4.9.4. Australia Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.4.10. South Korea
        • 9.4.10.1. South Korea Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.4.10.2. South Korea Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.4.10.3. South Korea Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.4.10.4. South Korea Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.4.11. Rest of Asia Pacific
        • 9.4.11.1. Rest of Asia Pacific Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.4.11.2. Rest of Asia Pacific Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.4.11.3. Rest of Asia Pacific Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.4.11.4. Rest of Asia Pacific Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America Anthelmintic Drugs Market Revenue 2016 – 2026 (USD Million)
      • 9.5.2. Latin America Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million)
      • 9.5.3. Latin America Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
      • 9.5.4. Latin America Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
      • 9.5.5. Latin America Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.5.6.2. Brazil Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.5.6.3. Brazil Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.5.6.4. Brazil Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.5.7. Argentina
        • 9.5.7.1. Argentina Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.5.7.2. Argentina Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.5.7.3. Argentina Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.5.7.4. Argentina Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.5.8. Rest of Latin America
        • 9.5.8.1. Rest of Latin America Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.5.8.2. Rest of Latin America Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.5.8.3. Rest of Latin America Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.5.8.4. Rest of Latin America Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
    • 9.6. Middle East & Africa
      • 9.6.1. Middle East & Africa Anthelmintic Drugs Market Revenue 2016 – 2026 (USD Million)
      • 9.6.2. Middle East & Africa Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
      • 9.6.3. Middle East & Africa Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
      • 9.6.4. Middle East & Africa Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
      • 9.6.5. Middle East & Africa Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.6.6. GCC Countries
        • 9.6.6.1. GCC Countries Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.6.6.2. GCC Countries Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.6.6.3. GCC Countries Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.6.6.4. GCC Countries Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.6.7. South Africa
        • 9.6.7.1. South Africa Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.6.7.2. South Africa Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.6.7.3. South Africa Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.6.7.4. South Africa Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
      • 9.6.8. Rest of MEA
        • 9.6.8.1. Rest of MEA Anthelmintic Drugs Market Revenue, by Drug Class, 2016 – 2026 (USD Million)
        • 9.6.8.2. Rest of MEA Anthelmintic Drugs Market Revenue, by Route of Administration, 2016 – 2026 (USD Million)
        • 9.6.8.3. Rest of MEA Anthelmintic Drugs Market Revenue, by Application, 2016 – 2026 (USD Million)
        • 9.6.8.4. Rest of MEA Anthelmintic Drugs Market Revenue, by Distribution Channel, 2016 – 2026 (USD Million)
  • Chapter 10. Company Profiles
    • 10.1. Novartis AG
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product portfulio
      • 10.1.4. Business strategy
      • 10.1.5. Recent developments
    • 10.2. *Same information will be provided for below mentioned companies*
      • 10.2.1. Cipla Inc.
      • 10.2.2. Sun Pharmaceutical Industries Ltd
      • 10.2.3. Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.)
      • 10.2.4. Zoetis, Inc.
      • 10.2.5. GlaxoSmithKline plc
      • 10.2.6. Bayer AG
      • 10.2.7. Merck & Co., Inc. (Intervet Inc.)
      • 10.2.8. Boehringer Ingelheim International GmbH
      • 10.2.9. Others

Table Of Figures

List of Figures 

1. Global Anthelmintic Drugs Market Segmentation by Drug Class, Route of Administration, Application, Distribution Channel and Geography
2. Global Anthelmintic Drugs Market, 2018-2026 (USD Million)
3. Porter’s Five Forces Analysis: Anthelmintic Drugs Market
4. Global Anthelmintic Drugs Market Attractiveness, by Drug Class
5. Global Anthelmintic Drugs Market Attractiveness, by Route of Administration
6. Global Anthelmintic Drugs Market Attractiveness, by Application
7. Global Anthelmintic Drugs Market Attractiveness, by Distribution Channel
8. Global Anthelmintic Drugs Market Attractiveness, by Regional
9. Global Anthelmintic Drugs Market Revenue Share, by Drug Class, 2019 & 2026 (USD Million)
10. Global Anthelmintic Drugs Market by Benzimidazoles, 2016 – 2026 (USD Million)
11. Global Anthelmintic Drugs Market by Piperazine, 2016 – 2026 (USD Million)
12. Global Anthelmintic Drugs Market by Imidazothiazole, 2016 – 2026 (USD Million)
13. Global Anthelmintic Drugs Market by Spiroindoles, 2016 – 2026 (USD Million)
14. Global Anthelmintic Drugs Market by Others, 2016 – 2026 (USD Million)
15. Global Anthelmintic Drugs Market Revenue Share, by Route of Administration, 2019 & 2026 (USD Million)
16. Global Anthelmintic Drugs Market by Oral, 2016 – 2026 (USD Million)
17. Global Anthelmintic Drugs Market by Injectable, 2016 – 2026 (USD Million)
18. Global Anthelmintic Drugs Market Revenue Share, by Application, 2019 & 2026 (USD Million)
19. Global Anthelmintic Drugs Market by Human, 2016 – 2026 (USD Million)
20. Global Anthelmintic Drugs Market by Animal, 2016 – 2026 (USD Million)
21. Global Anthelmintic Drugs Market Revenue Share, by Distribution Channel, 2019 & 2026 (USD Million)
22. Global Anthelmintic Drugs Market by Hospital Pharmacies, 2016 – 2026 (USD Million)
23. Global Anthelmintic Drugs Market by Retail Pharmacies, 2016 – 2026 (USD Million)
24. Global Anthelmintic Drugs Market by Online Pharmacies, 2016 – 2026 (USD Million)
25. Global Anthelmintic Drugs Market by Veterinary Pharmacies, 2016 – 2026 (USD Million)
26. Global Anthelmintic Drugs Market by Others, 2016 – 2026 (USD Million)
27. Global Anthelmintic Drugs Market Revenue Share, by Region, 2018-2026 (USD Million)
28. North America Anthelmintic Drugs Market, 2016-2026, (USD Million)
29. Europe Anthelmintic Drugs market, 2016-2026, (USD Million)
30. Asia Pacific Anthelmintic Drugs Market, 2016-2026(USD Million)
31. Latin America Anthelmintic Drugs Market, 2016 – 2026 (USD Million)
32. Middle East & Africa Anthelmintic Drugs Market, 2016 – 2026, (USD Million)
 


Table Of Tables

List of Tables

1. Global Anthelmintic Drugs market snapshot
2. Drivers for Anthelmintic Drugs market: Impact analysis
3. Restraints of Anthelmintic Drugs market: Impact analysis
4. North America Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
5. North America Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
6. North America Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
7. North America Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
8. U.S. Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
9. U.S. Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
10. U.S. Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
11. U.S. Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
12. Canada Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
13. Canada Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
14. Canada Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
15. Canada Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
16. Mexico Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
17. Mexico Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
18. Mexico Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
19. Mexico Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
20. Europe Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
21. Europe Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
22. Europe Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
23. Europe Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
24. UK Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
25. UK Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
26. UK Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
27. UK Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
28. France Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
29. France Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
30. France Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
31. France Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
32. Germany Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
33. Germany Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
34. Germany Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
35. Germany Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
36. Italy Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
37. Italy Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
38. Italy Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
39. Italy Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
40. Spain Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
41. Spain Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
42. Spain Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
43. Spain Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
44. Russia Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
45. Russia Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
46. Russia Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
47. Russia Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
48. Rest of Europe Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
49. Rest of Europe Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
50. Rest of Europe Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
51. Rest of Europe Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
52. Asia Pacific Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
53. Asia Pacific Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
54. Asia Pacific Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
55. Asia Pacific Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
56. China Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
57. China Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
58. China Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
59. China Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
60. Japan Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
61. Japan Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
62. Japan Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
63. Japan Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
64. India Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
65. India Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
66. India Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
67. India Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
68. Australia Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
69. Australia Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
70. Australia Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
71. Australia Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
72. South Korea Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
73. South Korea Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
74. South Korea Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
75. South Korea Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
76. Rest of Asia Pacific Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
77. Rest of Asia Pacific Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
78. Rest of Asia Pacific Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
79. Rest of Asia Pacific Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
80. Latin America Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
81. Latin America Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
82. Latin America Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
83. Latin America Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
84. Brazil Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
85. Brazil Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
86. Brazil Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
87. Brazil Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
88. Argentina Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
89. Argentina Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
90. Argentina Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
91. Argentina Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
92. Rest of Latin America Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
93. Rest of Latin America Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
94. Rest of Latin America Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
95. Rest of Latin America Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
96. Middle East & Africa Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
97. Middle East & Africa Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
98. Middle East & Africa Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
99. Middle East & Africa Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
100. GCC Countries Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
101. GCC Countries Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
102. GCC Countries Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
103. GCC Countries Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
104. South Africa Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
105. South Africa Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
106. South Africa Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
107. South Africa Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
108. Rest of MEA Anthelmintic Drugs Market Revenue, By Drug Class, 2016 – 2026 (USD Million) 
109. Rest of MEA Anthelmintic Drugs Market Revenue, By Route of Administration, 2016 – 2026 (USD Million)
110. Rest of MEA Anthelmintic Drugs Market Revenue, By Application, 2016 – 2026 (USD Million)
111. Rest of MEA Anthelmintic Drugs Market Revenue, By Distribution Channel, 2016 – 2026 (USD Million)
 

Methodology

FrequentlyAsked Questions

Effective use of anthelmintics in children is of significant public health interest since the parasites involved are likely to infect more than 2 billion people, most of whom are particularly prevalent and harmful in children. Properly targeted drug delivery, especially through community chemotherapy, can dramatically reduce aggregate mortality and morbidity as well as boost growth rates, physical activity and fitness, cognitive and academic performance and social well-being

According to Zion Market Research, the global Anthelmintic Drugs Market was worth USD 2.75 Billion in 2023. The market is forecast to reach USD 3.85 Billion by 2032, growing at a compound annual growth rate (CAGR) of 3.8% during the forecast period 2024-2032.

By Geography, the anthelmintic drugs market is segmented into North America, Europe, Latin America, Asia Pacific, and Middle East and Africa.

Europe accounted for the largest market for anthelmintic drugs in 2019, followed by Asia Pacific. The number of pet animals in the region is growing at a higher rate than that of livestock, leading to an increase in pet ownership, thereby the involvement of key players supplying anthelmintic drugs is also progressing. This, in turn, is expected to improve the growth of anthelmintic drugs market in the region.

The major players in the global anthelmintic drugs market include Novartis AG, Cipla Inc., Sun Pharmaceutical Industries Ltd, Amneal Pharmaceuticals LLC. (Impax Laboratories, Inc.), Zoetis, Inc., GlaxoSmithKline plc, Bayer AG, Merck & Co., Inc. (Intervet Inc.), and Boehringer Ingelheim International GmbH among others.

Choose License Type

  • zion payment modes

List of Contents

Market InsightsOverviewGrowth FactorsImpact due to the outbreak of COVID-19GlobalAnthelmintic DrugsSegmentationReport ScopeGlobalAnthelmintic DrugsMarket:Regional AnalysisGlobalAnthelmintic DrugsCompetitive PlayersThe report segment of global anthelmintic drugs market are as follows:Regional Segment Analysis

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed